Haurwitz Rachel E. 4
4 · Caribou Biosciences, Inc. · Filed Mar 22, 2023
Insider Transaction Report
Form 4
Haurwitz Rachel E.
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2023-03-20$2.96/sh+10,000$29,600→ 30,000 total - Exercise/Conversion
Option to purchase Common Stock
2023-03-20−10,000→ 106,350 totalExercise: $2.96Exp: 2023-06-11→ Common Stock (10,000 underlying)
Holdings
- 3,349,395(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Shares are held by The City Canyon Trust Dated May 31, 2021, of which the reporting person is a Co-Trustee with her spouse.
- [F2]1/4th of the shares subject to this option vested on June 12, 2019 and an additional 1/48th of the aggregate number of shares subject to the option vested on the corresponding day of each month thereafter until the option became fully vested on June 12, 2022.